Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: The filing lists the registrant as Zimmer Holdings, Inc., though the request metadata references Zimmer Biomet Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: July 26, 2012
Reporting Period: Quarter ended June 30, 2012
Context: The company reported its results of operations for the second quarter of 2012. The detailed earnings release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text serves as a cover report and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references an attached press release (Exhibit 99.1) for these figures.
Non-GAAP Measures Discussed:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Net Earnings and Diluted EPS: Adjusted to exclude specific items including:
- Inventory step-up.
- Provision for Durom Acetabular Component product claims.
- Special items (acquisition/integration costs, employee termination benefits, consulting fees, litigation, restructuring, and asset impairments).
- Certain tax adjustments.
Material Changes and Unusual Items
The filing highlights several unusual items excluded from adjusted performance measures, indicating material impacts on GAAP results:
- Product Liability: Provisions related to Durom Acetabular Component product claims.
- Restructuring and Transformation: Costs associated with global restructuring, including asset impairment charges and dedicated personnel expenses.
- Acquisition Costs: Expenses related to acquisition and integration.
- Other Special Items: Employee termination benefits, consulting/professional fees, certain litigation matters, and contract terminations.
The text does not provide specific year-over-year percentage changes or dollar amounts for these items.
Guidance, Outlook, and Management Commentary
Management Commentary: Management utilizes the non-GAAP measures internally to evaluate business performance, identify operating trends masked by special items, and perform trend analysis. Adjusted diluted EPS is also used as a metric in incentive compensation programs.
Guidance: The text mentions that the earnings release includes "projected adjusted diluted EPS," but the specific guidance figures are not present in this 8-K summary text.
Risks and Contingencies: The filing notes the existence of litigation matters and product claim provisions (Durom) as significant factors affecting financial results.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net earnings, and EPS figures for the quarter ended June 30, 2012.
- Verify the reconciliation between GAAP and non-GAAP measures to understand the exact financial impact of the Durom product claims and restructuring costs.
- Confirm the specific "projected adjusted diluted EPS" guidance provided in the attached press release.
- Assess the magnitude of foreign currency impacts by comparing reported sales growth versus constant currency sales growth.